RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 67 filers reported holding RECRO PHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $1,091,755 | +232.2% | 1,010,684 | +7.8% | 0.00% | – |
Q4 2023 | $328,670 | -11.3% | 937,534 | +18.7% | 0.00% | – |
Q3 2023 | $370,683 | -55.6% | 790,167 | +4.0% | 0.00% | – |
Q2 2023 | $835,607 | +11.9% | 759,643 | +21.1% | 0.00% | – |
Q1 2023 | $746,423 | +131081.5% | 627,247 | +64.1% | 0.00% | – |
Q4 2022 | $569 | -99.9% | 382,339 | +2.4% | 0.00% | – |
Q3 2022 | $608,000 | +106.8% | 373,304 | +0.7% | 0.00% | – |
Q2 2022 | $294,000 | -56.1% | 370,529 | -0.4% | 0.00% | – |
Q1 2022 | $669,000 | +11.3% | 372,005 | +5.7% | 0.00% | – |
Q4 2021 | $601,000 | -15.7% | 351,786 | +1.6% | 0.00% | – |
Q3 2021 | $713,000 | +0.8% | 346,208 | +13.0% | 0.00% | – |
Q2 2021 | $707,000 | -28.1% | 306,269 | -13.1% | 0.00% | – |
Q1 2021 | $983,000 | +32.1% | 352,367 | +34.9% | 0.00% | – |
Q4 2020 | $744,000 | +31.7% | 261,292 | -2.9% | 0.00% | – |
Q3 2020 | $565,000 | -54.1% | 269,157 | -0.6% | 0.00% | – |
Q2 2020 | $1,232,000 | -48.4% | 270,820 | -7.3% | 0.00% | -100.0% |
Q1 2020 | $2,387,000 | -77.3% | 292,187 | -49.0% | 0.00% | 0.0% |
Q4 2019 | $10,502,000 | +212.7% | 572,988 | +89.0% | 0.00% | 0.0% |
Q3 2019 | $3,358,000 | +3.1% | 303,155 | -5.4% | 0.00% | 0.0% |
Q2 2019 | $3,258,000 | +179.2% | 320,425 | +60.9% | 0.00% | – |
Q1 2019 | $1,167,000 | -47.9% | 199,155 | -37.0% | 0.00% | – |
Q4 2018 | $2,242,000 | +124.2% | 315,906 | +124.6% | 0.00% | – |
Q3 2018 | $1,000,000 | +49.5% | 140,654 | +5.4% | 0.00% | – |
Q2 2018 | $669,000 | -49.0% | 133,416 | +11.9% | 0.00% | – |
Q1 2018 | $1,312,000 | +23.8% | 119,233 | +4.0% | 0.00% | – |
Q4 2017 | $1,060,000 | +2.4% | 114,667 | -0.6% | 0.00% | – |
Q3 2017 | $1,035,000 | +29.4% | 115,358 | +1.3% | 0.00% | – |
Q2 2017 | $800,000 | +3.1% | 113,859 | +28.1% | 0.00% | – |
Q1 2017 | $776,000 | +44.8% | 88,853 | +33.5% | 0.00% | – |
Q4 2016 | $536,000 | +135.1% | 66,565 | +158.0% | 0.00% | – |
Q3 2016 | $228,000 | +11.8% | 25,801 | +0.1% | 0.00% | – |
Q2 2016 | $204,000 | +33.3% | 25,775 | 0.0% | 0.00% | – |
Q1 2016 | $153,000 | -34.1% | 25,775 | -0.1% | 0.00% | – |
Q4 2015 | $232,000 | -24.9% | 25,801 | +0.2% | 0.00% | – |
Q3 2015 | $309,000 | +19.8% | 25,749 | +28.8% | 0.00% | – |
Q2 2015 | $258,000 | +94.0% | 19,984 | +36.1% | 0.00% | – |
Q1 2015 | $133,000 | +224.4% | 14,684 | 0.0% | 0.00% | – |
Q4 2014 | $41,000 | -4.7% | 14,684 | 0.0% | 0.00% | – |
Q3 2014 | $43,000 | -63.2% | 14,684 | 0.0% | 0.00% | – |
Q2 2014 | $117,000 | – | 14,684 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samjo Capital LLC | 3,510,000 | $6,318,000 | 5.40% |
Cowen Prime Advisors LLC | 4,162,500 | $7,493,000 | 3.15% |
Athyrium Capital Management, LP | 2,202,420 | $3,964,000 | 1.41% |
AWM Investment Company, Inc. | 5,081,901 | $9,147,000 | 1.18% |
Parkman Healthcare Partners LLC | 671,817 | $1,209,000 | 0.35% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 799,841 | $1,440,000 | 0.18% |
Rubric Capital Management LP | 1,076,587 | $1,938,000 | 0.07% |
TITLEIST CAPITAL, LLC | 180,093 | $324,000 | 0.06% |
Clear Harbor Asset Management, LLC | 266,972 | $481,000 | 0.06% |
Frontier Wealth Management LLC | 64,605 | $2,701,000 | 0.03% |